Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized …
E Bria, F Cuppone, M Fornier, C Nisticò… - Breast cancer research …, 2008 - Springer
Background In five randomized clinical trials (RCTs), adjuvant trastuzumab (T) for early
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized …
E Bria, F Cuppone, M Fornier, C Nisticò… - … Cancer Research and …, 2007 - europepmc.org
Background In five randomized clinical trials (RCTs), adjuvant trastuzumab (T) for early
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized …
E Bria, F Cuppone, M Fornier… - … Cancer Research & …, 2008 - search.ebscohost.com
Abstract Abstract Background In five randomized clinical trials (RCTs), adjuvant trastuzumab
(T) for early stage breast cancer with human epidermal growth-factor receptor-2 over …
(T) for early stage breast cancer with human epidermal growth-factor receptor-2 over …
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized …
E Bria, F Cuppone, M Fornier, C Nisticò… - Breast Cancer Research …, 2008 - infona.pl
Background In five randomized clinical trials (RCTs), adjuvant trastuzumab (T) for early
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized …
E Bria, F Cuppone, M Fornier… - Breast cancer …, 2008 - pubmed.ncbi.nlm.nih.gov
Background In five randomized clinical trials (RCTs), adjuvant trastuzumab (T) for early
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized …
E Bria, F Cuppone, M Fornier, C Nisticò… - Breast Cancer …, 2008 - search.proquest.com
In five randomized clinical trials (RCTs), adjuvant trastuzumab (T) for early stage breast
cancer with human epidermal growth-factor receptor-2 over-expression/gene-amplification …
cancer with human epidermal growth-factor receptor-2 over-expression/gene-amplification …
Cardiotoxicity and Incidence Of Brain Metastases After Adjuvant Trastuzumab for Early Breast Cancer: The Dark Side of the Moon? A Meta-Analysis of The …
E Bria, F Cuppone, M Fornier, C Nisticò… - BREAST CANCER …, 2008 - iris.univr.it
BACKGROUND: In five randomized clinical trials (RCTs), adjuvant trastuzumab (T) for early
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
stage breast cancer with human epidermal growth-factor receptor-2 over-expression/gene …
[引用][C] Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the …
E BRIA, F CUPPONE, M FORMER… - Breast cancer …, 2008 - pascal-francis.inist.fr
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast
cancer : the dark side of the moon? A meta-analysis of the randomized trials CNRS Inist …
cancer : the dark side of the moon? A meta-analysis of the randomized trials CNRS Inist …
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized …
E Bria, F Cuppone, M Fornier… - … Cancer Research & …, 2008 - search.ebscohost.com
Abstract Abstract Background In five randomized clinical trials (RCTs), adjuvant trastuzumab
(T) for early stage breast cancer with human epidermal growth-factor receptor-2 over …
(T) for early stage breast cancer with human epidermal growth-factor receptor-2 over …